Stock Analysis on Net
Stock Analysis on Net

Johnson & Johnson (NYSE:JNJ)

Common-Size Income Statement 
Quarterly Data

Johnson & Johnson, common-size consolidated income statement (quarterly data)

Microsoft Excel
3 months ended: Sep 29, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Oct 1, 2023 Jul 2, 2023 Apr 2, 2023 Dec 31, 2022 Oct 2, 2022 Jul 3, 2022 Apr 3, 2022 Dec 31, 2021 Oct 3, 2021 Jul 4, 2021 Apr 4, 2021 Dec 31, 2020 Sep 27, 2020 Jun 28, 2020 Mar 29, 2020 Dec 29, 2019 Sep 29, 2019 Jun 30, 2019 Mar 31, 2019
Sales to customers 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost of products sold -30.99 -30.60 -30.45 -31.77 -30.94 -30.03 -32.00 -32.76 -32.81 -32.97 -32.43 -32.07 -31.07 -32.55 -31.64 -34.77 -33.07 -35.88 -34.13 -34.39 -33.13 -33.75 -33.04
Gross profit 69.01% 69.40% 69.55% 68.23% 69.06% 69.97% 68.00% 67.24% 67.19% 67.03% 67.57% 67.93% 68.93% 67.45% 68.36% 65.23% 66.93% 64.12% 65.87% 65.61% 66.87% 66.25% 66.96%
Selling, marketing and administrative expenses -24.38 -25.31 -24.58 -27.16 -25.29 -25.08 -23.48 -27.47 -25.59 -25.92 -25.35 -28.84 -25.71 -26.05 -24.34 -28.73 -25.76 -27.23 -25.15 -29.11 -25.93 -26.97 -26.07
Research and development expense -22.04 -15.32 -16.56 -20.94 -16.14 -17.21 -16.54 -16.20 -15.12 -15.42 -14.78 -19.03 -14.66 -14.56 -14.24 -17.94 -13.47 -14.76 -12.47 -15.58 -12.54 -12.97 -14.28
In-process research and development impairments 0.00 -0.86 0.00 -0.27 -0.96 0.00 -0.23 -0.73 0.00 0.00 -2.60 0.00 -3.86 0.00 0.00 -0.16 -0.65 -0.03 0.00 0.00 0.00 0.00 -4.45
Restructuring -0.18 0.06 -0.77 -0.26 -0.74 -0.67 -0.62 -0.35 -0.34 -0.35 -0.30 -0.33 -0.26 -0.24 -0.24 -0.27 -0.32 -0.33 -0.28 -0.50 -0.33 -0.28 -0.18
Operating earnings 22.42% 27.96% 27.63% 19.60% 25.92% 27.01% 27.12% 22.49% 26.13% 25.34% 24.54% 19.72% 24.45% 26.60% 29.55% 18.13% 26.72% 21.76% 27.97% 20.43% 28.08% 26.03% 21.99%
Interest income 1.30 1.76 1.70 1.70 1.75 1.51 0.95 1.07 0.63 0.27 0.09 0.05 0.06 0.05 0.07 0.06 0.06 0.10 0.32 0.39 0.43 0.43 0.49
Interest expense, net of portion capitalized -0.86 -1.20 -0.72 -0.71 -0.90 -1.01 -1.01 -0.75 -0.21 -0.16 -0.04 -0.24 -0.09 -0.17 -0.28 -0.39 -0.21 -0.25 -0.12 -0.41 -0.23 -0.40 -0.51
Other income (expense), net -8.00 -2.91 -11.24 1.97 -2.34 1.78 -33.22 -5.09 -2.07 -1.14 0.44 -0.04 -7.93 2.09 3.95 -10.47 -5.69 -0.13 3.28 -0.08 -20.33 8.19 0.11
Earnings (loss) before (provision for) benefit from taxes on income 14.85% 25.61% 17.37% 22.56% 24.43% 29.30% -6.16% 17.72% 24.47% 24.31% 25.02% 19.50% 16.49% 28.58% 33.28% 7.33% 20.88% 21.49% 31.46% 20.33% 7.95% 34.24% 22.09%
(Provision for) benefit from taxes on income -2.87 -4.73 -2.15 -3.24 -4.25 -4.32 3.81 -2.87 -5.73 -4.27 -3.04 -0.40 -0.78 -1.65 -5.52 0.40 -4.02 -1.71 -3.45 -1.00 0.51 -6.97 -3.36
Net earnings (loss) from continuing operations 11.99% 20.88% 15.22% 19.31% 20.18% 24.98% -2.35% 14.85% 18.74% 20.04% 21.98% 19.09% 15.71% 26.93% 27.76% 7.73% 16.86% 19.78% 28.01% 19.33% 8.46% 27.27% 18.73%
Net earnings (loss) from discontinued operations, net of tax 0.00 0.00 0.00 -0.39 101.72 -1.08 2.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net earnings (loss) 11.99% 20.88% 15.22% 18.92% 121.91% 23.90% -0.33% 14.85% 18.74% 20.04% 21.98% 19.09% 15.71% 26.93% 27.76% 7.73% 16.86% 19.78% 28.01% 19.33% 8.46% 27.27% 18.73%

Based on: 10-Q (reporting date: 2024-09-29), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-10-01), 10-Q (reporting date: 2023-07-02), 10-Q (reporting date: 2023-04-02), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-10-02), 10-Q (reporting date: 2022-07-03), 10-Q (reporting date: 2022-04-03), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-10-03), 10-Q (reporting date: 2021-07-04), 10-Q (reporting date: 2021-04-04), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-27), 10-Q (reporting date: 2020-06-28), 10-Q (reporting date: 2020-03-29), 10-K (reporting date: 2019-12-29), 10-Q (reporting date: 2019-09-29), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

Income statement item Description The company
Operating earnings The net result for the period of deducting operating expenses from operating revenues. Johnson & Johnson operating earnings as a percentage of sales to customers increased from Q1 2024 to Q2 2024 but then decreased significantly from Q2 2024 to Q3 2024.
Earnings (loss) before (provision for) benefit from taxes on income Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Johnson & Johnson earnings (loss) before (provision for) benefit from taxes on income as a percentage of sales to customers increased from Q1 2024 to Q2 2024 but then decreased significantly from Q2 2024 to Q3 2024.
Net earnings (loss) The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Johnson & Johnson net earnings (loss) as a percentage of sales to customers increased from Q1 2024 to Q2 2024 but then decreased significantly from Q2 2024 to Q3 2024.